THE IMPACT OF COVID-19 ON RANDOMIZED CLINICAL TRIALS
The COVID-19 pandemic has a major impact on the conduct of most on-going clinical trials, in particular on the treatment…
White papers
White papers
FDA Draft Guidance on Expansion Cohorts – Read IDDI Comments
FDA Draft Guidance on the Use of Expansion Cohorts in first-in-human clinical trials IDDI has submitted a comment on the Food…